Full Event Guide

5 Takeaways You Cannot Afford to Miss:

• Navigate developing surrogate endpoints and real-world evidence with the FDA, Bayer, and Pfizer
• Execute precision medicine approaches to targeted therapeutics with AstraZeneca, Goldfinch Bio, and University of Michigan
• Transform your translational strategy and confidently progress novel therapeutics to the clinic with Novo Nordisk, Johnson & Johnson, and Novartis
• Harness advances in innovative trial design with Chinook, GSK, National Kidney Foundation,
  and Boehringer Ingelheim
• Critically assess opportunities to target rare renal diseases with Sanofi, Otsuka, and Alexion